[TITLE]Mdxhealth Announces Closing of Exosome Diagnostics Acquisition from Bio-Techne:
[TEXT]
Mdxhealth Announces Closing of Exosome Diagnostics Acquisition from Bio-Techne

IRVINE, CA, and HERSTAL, BELGIUM – September 15, 2025 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH) (the "Company" or "mdxhealth"), a leading precision diagnostics company, today announced the closing of the ExoDx business acquisition from Bio-Techne Corporation, which includes the ExoDx Prostate test.

Acquisition of ExoDx Business

On August 5, 2025, mdxhealth signed a definitive agreement to acquire Exosome Diagnostics, Inc. from Bio-Techne, including the ExoDx Prostate (EPI) test, CLIA-certified clinical laboratory and related assets. Total consideration for the acquisition is $15 million, with $5 million in stock paid at closing and $2.5 million to be paid annually over the following 4 years with 50% in cash and 50% in cash or stock at mdxhealth’s discretion.

XMS Capital Partners acted as sole financial advisor and K&L Gates acted as lead legal counsel to the Company for this acquisition; Baker McKenzie served as lead legal counsel for Belgian corporate matters.
[Source link]: https://www.globenewswire.com/news-release/2025/09/15/3150431/0/en/Mdxhealth-Announces-Closing-of-Exosome-Diagnostics-Acquisition-from-Bio-Techne.html


[TITLE]People taking Novo Nordisk’s Wegovy® experienced reduced food noise and boosted mental well-being:
[TEXT]
Results from a real-world survey suggest that semaglutide for weight management (Wegovy ® ) helped suppress food noise – unwanted and intrusive thoughts
[Source link]: https://www.globenewswire.com/news-release/2025/09/15/3150448/0/en/People-taking-Novo-Nordisk-s-Wegovy-experienced-reduced-food-noise-and-boosted-mental-well-being.html

================================================================================

[TITLE]People taking Novo Nordisk’s Wegovy® experienced reduced food noise and boosted mental well-being:
[TEXT]
Results from a real-world survey suggest that semaglutide for weight management (Wegovy ® ) helped suppress food noise – unwanted and intrusive thoughts
[Source link]: https://www.globenewswire.com/news-release/2025/09/15/3150448/0/en/People-taking-Novo-Nordisk-s-Wegovy-experienced-reduced-food-noise-and-boosted-mental-well-being.html


[TITLE]Mdxhealth Announces Closing of Exosome Diagnostics Acquisition from Bio-Techne:
[TEXT]
Mdxhealth Announces Closing of Exosome Diagnostics Acquisition from Bio-Techne

IRVINE, CA, and HERSTAL, BELGIUM – September 15, 2025 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH) (the "Company" or "mdxhealth"), a leading precision diagnostics company, today announced the closing of the ExoDx business acquisition from Bio-Techne Corporation, which includes the ExoDx Prostate test.

Acquisition of ExoDx Business

On August 5, 2025, mdxhealth signed a definitive agreement to acquire Exosome Diagnostics, Inc. from Bio-Techne, including the ExoDx Prostate (EPI) test, CLIA-certified clinical laboratory and related assets. Total consideration for the acquisition is $15 million, with $5 million in stock paid at closing and $2.5 million to be paid annually over the following 4 years with 50% in cash and 50% in cash or stock at mdxhealth’s discretion.

XMS Capital Partners acted as sole financial advisor and K&L Gates acted as lead legal counsel to the Company for this acquisition; Baker McKenzie served as lead legal counsel for Belgian corporate matters.
[Source link]: https://www.globenewswire.com/news-release/2025/09/15/3150431/0/en/Mdxhealth-Announces-Closing-of-Exosome-Diagnostics-Acquisition-from-Bio-Techne.html

================================================================================

[Failed to load article at https://www.globenewire.com/news-release/2025/09/15/3150150/0/en/DNA-Vaccine-Market-Size-to-Expect-USD-1041-68-Million-by-2034.html]


[Failed to load article at https://www.globenewire.com/news-release/2025/09/15/3149884/0/en/Infertility-Drugs-Market-to-Reach-USD-6-36-Billion-by-2032-Gonadotropins-Segment-Leads-Growth-Online-Pharmacies-Emerging-as-Key-Distribution-Channel.html]


[Failed to load article at https://www.globenewire.com/news-release/2025/09/15/3150284/0/en/Active-Vacuum-Packaging-Technology-Market-Size-and-Share.html]


[Failed to load article at https://www.globenewire.com/news-release/2025/09/15/3149794/0/en/Infant-Incubator-Market-Size-to-Surpass-USD-3-04-Billion-by-2034-Driven-by-Rising-Preterm-Births-and-Smart-Care-Innovations.html]

================================================================================

No articles found for this sector...

================================================================================

[TITLE]People taking Novo Nordisk’s Wegovy® experienced reduced food noise and boosted mental well-being:
[TEXT]
Results from a real-world survey suggest that semaglutide for weight management (Wegovy ® ) helped suppress food noise – unwanted and intrusive thoughts
[Source link]: https://www.globenewswire.com/news-release/2025/09/15/3150448/0/en/People-taking-Novo-Nordisk-s-Wegovy-experienced-reduced-food-noise-and-boosted-mental-well-being.html


[TITLE]Mdxhealth Announces Closing of Exosome Diagnostics Acquisition from Bio-Techne:
[TEXT]
Mdxhealth Announces Closing of Exosome Diagnostics Acquisition from Bio-Techne

IRVINE, CA, and HERSTAL, BELGIUM – September 15, 2025 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH) (the "Company" or "mdxhealth"), a leading precision diagnostics company, today announced the closing of the ExoDx business acquisition from Bio-Techne Corporation, which includes the ExoDx Prostate test.

Acquisition of ExoDx Business

On August 5, 2025, mdxhealth signed a definitive agreement to acquire Exosome Diagnostics, Inc. from Bio-Techne, including the ExoDx Prostate (EPI) test, CLIA-certified clinical laboratory and related assets. Total consideration for the acquisition is $15 million, with $5 million in stock paid at closing and $2.5 million to be paid annually over the following 4 years with 50% in cash and 50% in cash or stock at mdxhealth’s discretion.

XMS Capital Partners acted as sole financial advisor and K&L Gates acted as lead legal counsel to the Company for this acquisition; Baker McKenzie served as lead legal counsel for Belgian corporate matters.
[Source link]: https://www.globenewswire.com/news-release/2025/09/15/3150431/0/en/Mdxhealth-Announces-Closing-of-Exosome-Diagnostics-Acquisition-from-Bio-Techne.html

================================================================================

